These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 36077373

  • 21. Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    Tsao S, Weber S, Cameron C, Nehme D, Ahmadzadeh E, Raymond M.
    J Antimicrob Chemother; 2016 Nov; 71(11):3125-3134. PubMed ID: 27402010
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. FK520 interacts with the discrete intrahelical amino acids of multidrug transporter Cdr1 protein and acts as antagonist to selectively chemosensitize azole-resistant clinical isolates of Candida albicans.
    Nim S, Rawal MK, Prasad R.
    FEMS Yeast Res; 2014 Jun; 14(4):624-32. PubMed ID: 24628911
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.
    Luna-Tapia A, Kerns ME, Eberle KE, Jursic BS, Palmer GE.
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2410-20. PubMed ID: 25666149
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N, Hdayed D, Geukgeuzian G, Tokajian S, Khalaf RA.
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [Abstract] [Full Text] [Related]

  • 30. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Make azoles active again: chalcones as potent reversal agents of transporters-mediated resistance in Candida albicans.
    Nim S, Baghel P, Tran-Nguyen VK, Peres B, Nguyen KA, Pietro AD, Falson P, Prasad R, Boumendjel A.
    Future Med Chem; 2018 Sep 01; 10(18):2177-2186. PubMed ID: 30043631
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW, Cruz MC, Katiyar SK, Edlind TD.
    Antimicrob Agents Chemother; 1999 Aug 01; 43(8):1968-74. PubMed ID: 10428921
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.